Musculoskeletal System

These ingredients are often used in alternative medicine to support musculoskeletal system.

• AKG (alpha-ketoglutarate)Scientific

  AKG has extensive evidence in the musculoskeletal system, spanning both muscle and bone. It stimulates muscle protein synthesis, inhibits degradation, activates satellite cells, and improves nitrogen balance in catabolic states. In bone, it reduces resorption and supports osteoblast differentiation. Human RCTs support its use in postmenopausal bone loss, burn/surgical patients, and exercise recovery.

• ALA (alpha-linolenic acid)Scientific

  ALA has documented anti-osteoporotic effects, particularly via flaxseed supplementation, and reduces musculoskeletal inflammation relevant to arthritis and rheumatic conditions. Evidence links ALA intake to improved bone mineral density and reduced joint inflammatory damage.

• alpha D-ribofuranoseScientific

  D-ribose supports ATP resynthesis in skeletal muscle following high-intensity exercise, with clinical studies showing reduced DOMS, lower creatine kinase levels, and improved recovery in exercised muscle. Benefits are most evident in less-trained individuals and high-intensity exercise paradigms.

• amaranthScientific

  Amaranth is rich in calcium, phosphorus, magnesium, and lysine — all essential for bone and muscle function. Vitamin K in amaranth leaves promotes osteoblastic activity and bone mass. Lysine enhances calcium absorption and is required for collagen synthesis in connective tissue. Evidence is primarily nutritional and compositional, supporting bone and muscle health through micronutrient supply.

• anchoviesScientific

  Anchovies support the musculoskeletal system through calcium and phosphorus for bone mineralization, high-quality protein for muscle synthesis, and EPA/DHA for anti-inflammatory support of muscle recovery and sarcopenia prevention. Clinical evidence documents omega-3 benefits for muscle mass, strength, and physical performance in older adults.

• anemarrhena asphodeloidesScientific

  Anemarrhena has well-documented effects on bone and joint health: anti-osteoporotic activity increasing bone mineral density in OVX mouse models, anti-arthritic effects via sarsasapogenin's PKM2 targeting in rheumatoid fibroblast-like synoviocytes, and modulation of bone resorption markers. The Guizhi Shaoyao Zhimu formula is named for joint conditions.

• annattoScientific

  Annatto tocotrienol has demonstrated benefits for both bone and joint health in multiple animal studies and one human RCT, reducing bone resorption markers and improving bone turnover in postmenopausal women. The mechanisms include RANKL/OPG ratio modulation, antioxidant protection of osteoblasts, and Wnt pathway modulation. Evidence for joint health (cartilage/arthritis) remains preclinical.

• arginine alpha ketoglutarateScientific

  Both the arginine and AKG components of AAKG influence musculoskeletal function. AKG promotes muscle protein synthesis, inhibits catabolic pathways, and supports muscle satellite cell activation, while arginine supplies NO for muscle blood flow and stimulates GH/IGF-1. A 2024 systematic narrative review of 112 studies confirmed AKG's role in skeletal muscle regeneration and atrophy prevention.

• arnicaScientific

  Arnica has its primary evidence base in musculoskeletal applications. The German Commission E and EMA both approve topical arnica for dislocations, contusions, fracture edema, and rheumatic muscle and joint pain. Multiple RCTs and a 2024 PRISMA systematic review confirm efficacy for osteoarthritis of the knee and hand, with mixed evidence for DOMS and post-surgical musculoskeletal pain.

• ashwagandhaScientific

  Ashwagandha (Withania somnifera) has multiple lines of clinical evidence supporting its role in musculoskeletal health, including improving muscle strength, muscle mass, and exercise recovery, as well as reducing joint pain and inflammation. Multiple randomized, double-blind, placebo-controlled trials in humans have demonstrated these effects. The active compounds—primarily withanolides such as withaferin A—exert anti-inflammatory actions via NF-κB pathway inhibition and promote muscle cell differentiation, providing a plausible mechanistic basis for the observed clinical outcomes.

• astaxanthinScientific

  Astaxanthin demonstrates significant activity in the musculoskeletal system: it reduces exercise-induced muscle damage and soreness in human RCTs, and in vitro and animal studies confirm enhancement of osteoblast activity, inhibition of osteoclastogenesis, and recovery of bone mineral density. Both bone and skeletal muscle benefit through shared antioxidant and anti-inflammatory mechanisms.

• ATP (adenosine triphosphate)Scientific

  Multiple RCTs and a systematic review/meta-analysis confirm that oral ATP disodium supplementation (400 mg/day) improves musculoskeletal performance, including gains in maximal strength, muscle thickness, lean mass, and power in resistance-trained individuals. ATP also reduces muscle protein breakdown during periods of high training stress. Extracellular ATP enhances skeletal muscle excitability by increasing calcium permeability and blocking chloride efflux via purinergic receptors.

• avian cartilageScientific

  Avian (chicken) cartilage is a primary source of undenatured type II collagen (UC-II), which has been evaluated in multiple human randomized controlled trials for musculoskeletal conditions including knee osteoarthritis and rheumatoid arthritis. Clinical evidence shows UC-II at 40 mg/day significantly reduces joint pain, stiffness, and functional impairment compared to placebo and glucosamine-chondroitin. The proposed mechanism involves oral tolerance induction via T-regulatory cells, suppressing cartilage-directed inflammation.

• bambooScientific

  Bamboo's silica content supports bone collagen formation, osteoblast activity, and bone mineral density; dietary silicon intake is positively correlated with BMD in epidemiological studies. Bamboo's anti-inflammatory compounds inhibit NF-κB and COX pathways relevant to musculoskeletal inflammation. Traditional medicine across Asia uses bamboo extensively for bones, joints, and connective tissue.

• bananaScientific

  Banana's potassium and magnesium supply electrolytes essential for muscle contraction and bone mineral balance. Dietary potassium reduces urinary calcium excretion, supporting bone mineral density indirectly. Exercise RCTs confirm banana effectively fuels muscle energy substrate utilization during prolonged exertion comparably to sports drinks.

• barrenwortScientific

  Epimedium is one of the most researched natural agents for musculoskeletal health, with clinical evidence for BMD preservation in postmenopausal women and extensive preclinical evidence for osteoblast stimulation, osteoclast inhibition, and joint-protective effects. ICA promotes BMSC osteogenic differentiation via BMP-2/SMAD4/Cbfa1, MAPK, and estrogen receptor pathways.

• beef proteinScientific

  Beef protein directly supports the musculoskeletal system through its role in muscle protein synthesis, lean mass accretion, and connective tissue remodeling. RCTs and meta-analyses demonstrate improvements in lean body mass, muscle strength, and musculoskeletal function with beef protein supplementation.

• beta-alanineScientific

  The musculoskeletal system is the primary site of BA action. BA is the rate-limiting precursor to carnosine, which is concentrated in skeletal muscle (type II fibers particularly), where it acts as a pH buffer, antioxidant, and calcium sensitizer. Supplementation at 2–6 g/day raises muscle carnosine by 20–80%, improving high-intensity exercise capacity, attenuating neuromuscular fatigue, and in aging populations, countering sarcopenia-associated declines in muscle function.

• beta-caroteneScientific

  Dietary beta-carotene intake is associated with preservation of bone mineral density, with a Bayesian meta-analysis of 12,521 individuals showing a significant protective effect (RR 0.89). Preclinical evidence shows beta-carotene directly inhibits osteoclastogenesis via NF-κB/RANKL pathway suppression. Lower beta-carotene status is found in osteoarthritis patients, particularly those with obesity-driven inflammation.

• black teaScientific

  Epidemiological evidence links habitual black tea consumption with preservation of bone mineral density and reduced fracture risk. Thearubigins and theaflavins inhibit osteoclast activity in animal models. Human data are predominantly observational rather than from interventional trials.

• blueberryScientific

  Blueberry polyphenols support musculoskeletal health through both muscle recovery (RCT evidence for faster strength recovery post-eccentric exercise) and bone density (RCT evidence for increased calcium retention in postmenopausal women and observational links to higher BMD).

• borage oilScientific

  The strongest clinical evidence for borage oil targets the musculoskeletal system via RA: multiple RCTs and a Cochrane review demonstrate significant reductions in joint tenderness, swelling, morning stiffness, and disease activity. GLA also has preclinical support for bone density preservation via anti-inflammatory mechanisms.

• boronScientific

  Boron is a trace mineral with accumulating human and clinical evidence supporting its role in musculoskeletal health, particularly for bone integrity and osteoarthritis. Its primary mechanisms involve reducing urinary excretion of calcium and magnesium, elevating vitamin D bioavailability, and inhibiting pro-inflammatory serine proteases. Clinical trials are small but controlled, and epidemiological data consistently link low boron intake to higher arthritis prevalence. The NIH Office of Dietary Supplements recognizes this evidence base while noting that larger confirmatory trials are still needed.

• boswelliaScientific

  Boswellia serrata (Indian frankincense) has substantial clinical evidence supporting its use in musculoskeletal conditions, primarily osteoarthritis. Multiple RCTs and meta-analyses demonstrate significant reductions in joint pain, stiffness, and improvements in physical function. Its primary bioactive compound, AKBA, inhibits the 5-lipoxygenase (5-LOX) enzyme, thereby reducing pro-inflammatory leukotrienes. Evidence quality is considered moderate, with some methodological limitations noted across trials.

• boswellic acidScientific

  Boswellic acids, pentacyclic triterpenoids from Boswellia serrata resin, have robust clinical evidence supporting their use for musculoskeletal conditions, particularly osteoarthritis (OA) and joint pain. Their primary mechanism involves potent inhibition of 5-lipoxygenase (5-LOX) and suppression of NF-κB signaling, reducing pro-inflammatory leukotrienes and cytokines implicated in cartilage degradation and synovitis. A 2020 meta-analysis of seven RCTs (n=545) found Boswellia extracts significantly reduced joint pain and stiffness while improving function versus controls. Traditional Ayurvedic use as an antirheumatic agent preceded this modern clinical validation by centuries.

• bovine heartScientific

  Bovine heart is a complete protein source providing all essential amino acids alongside L-carnitine. L-carnitine at clinical doses has been shown in RCTs to reduce exercise-induced muscle damage, attenuate muscle soreness, and in older adults, increase muscle mass. The high-quality protein supports structural musculoskeletal repair.

• broccoliScientific

  Sulforaphane has been specifically investigated for its potential to protect cartilage and joint tissue in osteoarthritis, inhibit osteoclastic bone resorption, and reduce articular inflammation. Human feeding studies confirm detectable sulforaphane in synovial fluid after broccoli consumption. Broccoli also provides vitamin K, calcium, and vitamin C essential for bone and connective tissue.

• bromelainScientific

  Bromelain, a proteolytic enzyme extract from pineapple, has documented anti-inflammatory and analgesic effects relevant to the musculoskeletal system, particularly for osteoarthritis and soft tissue injuries. Multiple clinical trials and reviews published in peer-reviewed journals support its use for reducing joint pain, stiffness, and swelling. Mechanistically, it suppresses pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8) via NF-κB and MAPK signaling pathways and exerts chondroprotective effects on articular cartilage. Evidence is promising but mixed, with some RCTs showing no significant benefit over placebo, indicating the overall body of evidence remains preliminary.

• brown rice proteinScientific

  A 2013 RCT (Nutrition Journal, n=24 resistance-trained males, 8 weeks, 48 g/day) found rice protein isolate produced equivalent improvements in skeletal muscle hypertrophy, strength, power, and lean mass to whey protein. Brown rice protein contains ≈18% BCAAs that support myofibrillar protein synthesis. A 2025 Frontiers in Nutrition review confirmed that plant protein blends including brown rice protein achieve muscle protein synthesis rates comparable to whey.

• caesalpinia cristaScientific

  C. crista has preclinical evidence for analgesic and anti-inflammatory effects relevant to musculoskeletal conditions. Seed extracts demonstrated significant analgesic activity in writhing and tail immersion models, and anti-inflammatory activity (74.2% paw edema inhibition). Traditional use for rheumatism, pain, and muscle conditions is documented.

• calciumScientific

  Calcium is the most abundant mineral in the body and is foundational to musculoskeletal health, comprising the structural matrix of bone and enabling muscle contraction. The NIH Office of Dietary Supplements identifies bone health as the primary basis for calcium's Dietary Reference Intakes. Clinical evidence from multiple RCTs and meta-analyses demonstrates that adequate calcium intake reduces bone loss and, in high-risk or deficient populations, lowers fracture risk—though benefits in healthy community-dwelling adults are less consistent. Recommended intakes range from 1,000–1,200 mg/day for adults, ideally alongside vitamin D.

• camphor oilScientific

  Camphor oil's analgesic, anti-inflammatory, and rubefacient effects on the musculoskeletal system are supported by human studies and OTC regulatory recognition. Key evidence includes a 2014 human study demonstrating increased muscle blood flow, a 2015 case series for muscular pain relief, and mechanistic studies confirming TRPV1/TRPA1 modulation.

• capsaicinoidsScientific

  Capsaicin has extensive clinical evidence for musculoskeletal pain relief, including FDA-approved high-concentration patches for neuropathic pain and multiple RCTs for osteoarthritis, rheumatoid arthritis, fibromyalgia, and post-exercise muscle soreness. The musculoskeletal system represents the most clinically validated therapeutic domain for capsaicinoids.

• capsicumScientific

  Capsaicin is a well-established topical analgesic for musculoskeletal pain conditions including osteoarthritis, rheumatoid arthritis, neck pain, and low back pain, recognized by the U.S. FDA as an OTC counterirritant. Multiple RCTs confirm pain-reducing effects through substance P depletion in musculoskeletal tissues.

• caryophylleneScientific

  BCP reduces musculoskeletal inflammation and joint damage in arthritis models, protects chondrocyte viability in human cells, and mechanistically targets CB2 and PPAR-γ expressed in synovial and cartilage tissues.

• caseinScientific

  Casein provides sustained amino acid delivery that supports muscle protein synthesis and bone mineral density. Casein phosphopeptides enhance intestinal calcium absorption, supporting bone mineralization. Clinical trials demonstrate that casein supplementation supports lean mass gains and attenuates sarcopenia-related muscle loss in older adults when combined with resistance training.

• cat's clawScientific

  Cat's Claw (Uncaria tomentosa/guianensis) has been the subject of multiple small randomized controlled trials for osteoarthritis and rheumatoid arthritis, establishing a clinical evidence base for its use in musculoskeletal conditions. Its key bioactive compounds—pentacyclic oxindole alkaloids and quinovic acid glycosides—are proposed to suppress pro-inflammatory mediators including NF-κB and TNF. However, NCCIH and institutional reviewers caution that existing trials are small, methodologically limited, and do not yet support definitive clinical recommendations.

• catechinsScientific

  Catechins protect skeletal muscle from exercise-induced oxidative damage, support muscle recovery, maintain muscle contractile properties, and modulate bone metabolism by promoting osteoblastogenesis and inhibiting osteoclastogenesis. Both muscle and bone effects are documented in animal and human studies.

• cauliflowerScientific

  Cauliflower provides vitamin K for osteocalcin activation and bone mineralization, and vitamin C for collagen synthesis in bone and cartilage. Sulforaphane reduces NF-κB activity relevant to osteoclastogenesis. Human meta-analyses of vitamin K and C support bone density maintenance in the context of a vitamin-rich diet.

• cherryScientific

  Tart cherry has been extensively studied for musculoskeletal applications including exercise-induced muscle damage, DOMS, osteoarthritis, and gout. RCTs support significant reductions in muscle soreness, faster strength recovery, lowered hsCRP in knee OA, and reduced gout flare risk via urate-lowering and anti-inflammatory effects.

• chia seedScientific

  Chia seeds are rich in calcium, phosphorus, magnesium, and manganese essential for bone matrix maintenance, plus protein and ALA for muscle tissue support. Animal studies show increased bone mineral content with chia. Protein content is relevant to post-exercise muscle protein synthesis, though chia-specific muscle RCTs are limited.

• chickpea proteinScientific

  Chickpea protein provides a plant-based amino acid source supporting muscle protein synthesis and skeletal maintenance. Amino acid digestibility of extruded chickpea protein is documented as high in human stable-isotope tracer studies. Chickpea-derived protein also supplies iron and magnesium relevant to muscle function and oxygen transport in the musculoskeletal system.

• chinese salvia rootScientific

  Danshen has been studied for osteoporosis, osteoarthritis, rheumatoid arthritis, fracture healing, and tendon repair under the umbrella of musculoskeletal diseases. Clinical trials for osteoporosis and mechanistic data for joint diseases support its relevance to this body system. Its angiogenesis-promoting properties aid bone and tendon tissue repair.

• chondroitinScientific

  Chondroitin sulfate (CS) is a naturally occurring glycosaminoglycan and structural component of articular cartilage, and is extensively studied for its role in supporting the musculoskeletal system—primarily in osteoarthritis (OA). Multiple RCTs and systematic reviews confirm that pharmaceutical-grade CS reduces pain and improves joint function in knee, hip, and hand OA. Evidence is conflicting across product grades, with the clearest benefit demonstrated for highly purified, pharmaceutical-grade formulations. It is classified by EULAR as a Symptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA).

• chymotrypsinScientific

  Chymotrypsin has been studied extensively in musculoskeletal contexts including fractures, orthopedic surgery, sprains, and sciatica. Multiple RCTs confirm reduction of edema, hematoma, and pain in orthopedic patients. It reduces edema and hemorrhagic infiltration in fracture and surgery settings.

• cissus quadrangularisScientific

  Cissus quadrangularis (CQ) has documented human clinical evidence supporting its role in bone healing, bone density preservation, and joint pain reduction. Key bioactive compounds — β-sitosterol, lupeol, quercetin, isorhamnetin, and vitamin C — drive osteogenic, anti-inflammatory, and anti-osteoclastogenic effects. Human RCTs and a 2025 systematic review/meta-analysis confirm measurable effects on bone biomarkers and fracture healing, though evidence remains limited by small sample sizes and variable study designs. Preclinical data (animal and cell-line models) is robust, but larger, well-controlled trials are still needed.

• CLA (conjugated linoleic acid)Scientific

  CLA has demonstrated effects on both muscle and bone components of the musculoskeletal system. Multiple RCTs show CLA increases lean body mass and reduces fat mass, with anti-catabolic effects during resistance training. Preliminary evidence also supports bone marker improvements, particularly in RA patients.

• clematisScientific

  The musculoskeletal system is the primary therapeutic target across Clematis traditions and its most clinically studied domain. Wei Ling Xian (TCM) is formally indicated for joint pain, rheumatism, and musculoskeletal stiffness. SKI306X (C. mandshurica) has clinical trial evidence for osteoarthritis and rheumatoid arthritis pain relief and cartilage protection.

• cod liver oilScientific

  Cod liver oil supports the musculoskeletal system through vitamin D–mediated calcium absorption and bone mineralization, omega-3-mediated joint inflammation reduction, and vitamin A support of connective tissue differentiation. CLO has documented effects on RA joint pain, bone density, and muscle recovery.

• coixScientific

  Coix seed demonstrates anti-arthritic, analgesic, and anti-inflammatory effects on musculoskeletal tissue in preclinical models. Its TCM application for arthralgia and 'dampness-bi' syndrome affecting joints and muscles is supported by animal model evidence.

• coleus forskohliiScientific

  Coleus forskohlii supplementation produced significant changes in bone mass and body composition in a clinical RCT. The cAMP pathway provides mechanistic support for osteoblast-mediated bone formation. One 12-week double-blind trial in overweight men is the primary human evidence.

• collagenScientific

  Collagen is a structural protein that forms a major constituent of bone, cartilage, tendons, and ligaments, making it intrinsically tied to musculoskeletal integrity. Multiple systematic reviews and meta-analyses of randomized controlled trials (RCTs) demonstrate that oral collagen supplementation (hydrolyzed peptides or undenatured type II) reduces joint pain and improves function in knee osteoarthritis, supports tendon structural adaptation, and may enhance bone mineral density. Evidence quality is generally low-to-moderate due to heterogeneous protocols and small sample sizes, but clinical signals are consistent across several large meta-analyses.

• collardScientific

  Collard greens are one of the richest plant sources of both calcium and vitamin K, critical for bone mineral density and fracture prevention. Their calcium (~300mg/cup cooked) is more bioavailable than from high-oxalate greens such as spinach. Vitamin K activates bone Gla proteins including osteocalcin. Magnesium in collards further supports bone density and muscle function.

• colostrumScientific

  Bovine colostrum's IGF-1, EGF, and growth factors promote both muscle protein synthesis and bone mineralization, addressing the musculoskeletal system holistically. RCTs demonstrate lean mass gains in athletes and improved physical disability in fracture patients. Growth factor-mediated mechanisms support both bone and muscle compartments.

• comfreyScientific

  Topical comfrey root extract is clinically proven for multiple musculoskeletal conditions including acute myalgia, back pain, sprains, contusions, strains, and osteoarthritis. Multiple RCTs, ESCOP, and the German Commission E all substantiate comfrey's efficacy across the musculoskeletal system. It is one of the most strongly evidenced herbal topical treatments for musculoskeletal pain and injury.

• commiphoraScientific

  Commiphora mukul has clinical evidence for osteoarthritis and preclinical evidence for rheumatoid-type arthritis. Guggulsterones reduce joint inflammation via NF-κB inhibition; C. myrrha extract is documented for trauma, fractures, and joint pain across multiple traditional systems with emerging clinical validation.

• copperScientific

  Copper is essential for bone matrix cross-linking via lysyl oxidase, and copper deficiency causes osteoporosis in humans. Approximately 50–70% of total body copper is distributed in muscle and bone. Clinical evidence documents copper-deficiency osteoporosis reversible with supplementation, and in vitro bone studies show copper regulates osteoblast and osteoclast activity.

• CoQ10 (coenzyme Q10)Scientific

  Skeletal muscle has high mitochondrial density and CoQ10 is essential for its ATP synthesis. The most clinically validated musculoskeletal effect is amelioration of statin-associated muscle symptoms (myalgia, weakness, cramps). Multiple meta-analyses of RCTs support CoQ10's role in reducing statin-induced muscle pain and tiredness. Additionally, CoQ10 has been studied for exercise-related muscle fatigue.

• creatineScientific

  Creatine has robust clinical and meta-analytic support for its role in the musculoskeletal system. By expanding intramuscular phosphocreatine stores, it accelerates ATP resynthesis during high-intensity contractions, directly augmenting muscle force output. Multiple systematic reviews and meta-analyses of randomized controlled trials confirm that creatine supplementation combined with resistance training increases lean muscle mass and upper-body strength in both younger and older adults. Evidence for bone mineral density benefits is less consistent, with some meta-analyses showing no significant effect on BMD despite possible improvements in bone geometry.

• creatine monohydrateScientific

  Creatine monohydrate is among the most robustly evidenced nutritional interventions for musculoskeletal health. Hundreds of RCTs and multiple systematic reviews confirm significant improvements in muscle strength, lean mass, and physical function, particularly when combined with resistance training across all age groups.

• cryptoxanthinScientific

  BCX has demonstrated effects on bone mineral density, osteoblast stimulation, osteoclast inhibition, and protection against cartilage degradation—all components of musculoskeletal system integrity. Evidence spans in vitro, animal, and human epidemiological data.

• curcuminScientific

  Curcumin has substantial clinical evidence supporting its use for musculoskeletal conditions, particularly osteoarthritis (OA) and rheumatoid arthritis (RA). Multiple randomized controlled trials and meta-analyses demonstrate significant reductions in joint pain, stiffness, and inflammatory markers. Its primary mechanism involves inhibition of the NF-κB signaling pathway, suppressing pro-inflammatory mediators including TNF-α, IL-1β, IL-6, and COX-2. Evidence quality is generally low-to-moderate, limited by small sample sizes, heterogeneous formulations, and bioavailability challenges.

• D-riboseScientific

  D-ribose has documented effects on skeletal muscle ATP replenishment following high-intensity exercise, with human clinical data supporting reduced DOMS and improved recovery in untrained individuals and disease populations. The mechanism is acceleration of purine nucleotide resynthesis via the pentose phosphate pathway.

• daidzinScientific

  Daidzin and its aglycone daidzein promote osteogenesis and inhibit osteoclastogenesis in animal and cell culture models via estrogen receptor-mediated and immune-mediated mechanisms. Comparative studies in ovariectomized rats confirm bone loss reduction. Clinical evidence comes from mixed isoflavone trials showing modest BMD protection.

• devil's clawScientific

  Devil's Claw (Harpagophytum procumbens) has substantial human clinical evidence supporting its use for musculoskeletal conditions, particularly low back pain and osteoarthritis. Multiple randomized controlled trials and systematic reviews demonstrate meaningful reductions in pain and improved mobility. Its principal bioactive constituents—iridoid glycosides, chiefly harpagoside—are believed to exert anti-inflammatory effects partly through inhibition of TNF-α and COX-2 pathways. Evidence strength is moderate-to-strong for standardized extracts delivering ≥50 mg harpagoside daily, with a safety profile generally superior to NSAIDs.

• DHA (docosahexaenoic acid)Scientific

  DHA (as part of omega-3 PUFAs) has well-documented clinical evidence supporting musculoskeletal health across multiple domains: reducing joint pain and inflammation in arthritis, attenuating exercise-induced muscle damage, and stimulating muscle protein synthesis to counter sarcopenia. Multiple RCTs and meta-analyses confirm statistically significant, though modest, benefits. The primary mechanisms involve DHA's anti-inflammatory properties, suppression of proteasomal muscle protein degradation, and upregulation of the mTORC1 anabolic signaling pathway.

• DHEA (dehydroepiandrosterone)Scientific

  DHEA is a precursor for androgens and estrogens that support both muscle anabolism and bone mineral density. Skeletal muscles can locally synthesize androgens and estrogens from DHEA, enabling intracrine anabolic support. Pooled RCT data show DHEA increases lean mass in women and reduces fat mass in men; effects on bone density are clearest in women.

• docosahexaenoic acidScientific

  DHA contributes to musculoskeletal health through anti-inflammatory effects in joints and muscles, and potential grip strength and exercise performance benefits. Maternal DHA supplementation during lactation has been associated with enhanced grip strength and prolonged swimming endurance in offspring. DHA's role in rheumatoid arthritis joint inflammation is documented in clinical RCTs.

• dodderScientific

  Dodder has well-documented effects on the musculoskeletal system through anti-osteoporotic mechanisms (RANKL/OPG modulation, increased bone mineral density) and anti-inflammatory/antinociceptive properties relevant to joints and muscles. Preclinical studies show benefits for both osteoporosis and knee osteoarthritis models. Traditional use for lower back and knee pain is extensively documented.

• dog roseScientific

  Rosa canina is one of the most clinically studied herbal remedies for musculoskeletal health, with moderate-quality evidence from multiple RCTs and meta-analyses demonstrating significant pain reduction and improved joint mobility in osteoarthritis patients. Anti-inflammatory mechanisms at the chondrocyte and synoviocyte level underpin the clinical findings.

• drynariaScientific

  Drynaria (Rhizoma Drynariae, known in TCM as 'Gu Sui Bu' or 'bone fractures healer') has a well-documented relationship with the musculoskeletal system, supported by both centuries of traditional use in Chinese medicine and a substantial body of peer-reviewed preclinical research. Its primary active constituents — flavonoids, especially naringin — have been shown in multiple animal models to promote fracture healing, increase bone mineral density, stimulate osteoblast differentiation, and inhibit osteoclast activity. Evidence comes from in vitro cell studies, ovariectomized rat osteoporosis models, and hindlimb-unloading disuse models, but robust human clinical trials remain lacking.

• EGCG (epigallocatechin gallate)Scientific

  EGCG has documented preclinical and emerging human-level scientific evidence supporting its role in musculoskeletal health, particularly for osteoarthritis (OA), rheumatoid arthritis (RA), bone density, and skeletal muscle preservation. Its primary mechanisms involve anti-inflammatory, antioxidant, and cartilage-protective actions. Human observational data link habitual green tea/EGCG consumption to higher bone mineral density and lower knee OA incidence, though large-scale interventional RCTs in musculoskeletal populations remain limited. Evidence is strongest in cell and animal models, with translational human data still accumulating.

• eggScientific

  Eggs contribute to musculoskeletal health through high-quality protein for muscle protein synthesis, vitamin D for bone mineralization, and ESM-derived collagen and glycosaminoglycans for joint and connective tissue support. RCTs across all three domains support this relationship.

• eicosapentaenoic acidScientific

  EPA reduces musculoskeletal inflammation in RA, OA, and exercise-induced muscle damage. At least 17 RCTs demonstrated EPA-containing fish oil improves RA joint symptoms. EPA also preserves skeletal muscle mitochondrial function in aging and protects chondrocytes from inflammatory degradation.

• enicostemma littoraleScientific

  Preclinical data document analgesic and anti-arthritic activity relevant to the musculoskeletal system, including reduction of paw edema in the CFA arthritis model and significant analgesic activity in hot plate and tail immersion tests. Traditional use for rheumatism across Ayurveda and Siddha further supports this relationship.

• EPA (eicosapentaenoic acid)Scientific

  EPA (eicosapentaenoic acid) has substantial clinical and mechanistic evidence supporting its role in the musculoskeletal system. It reduces joint pain and morning stiffness in inflammatory arthritis, attenuates exercise-induced muscle damage, and counters muscle wasting (cachexia/sarcopenia) via anti-inflammatory and anabolic signaling pathways. Multiple RCTs and meta-analyses underpin these effects, though effect sizes are generally modest and optimal dosing remains under investigation.

• eucommiaScientific

  Eucommia's musculoskeletal effects are among its most evidence-rich domains, spanning bone density enhancement (meta-analysis of 18 RCTs in animal models), anti-arthritic activity (CIA models), collagen synthesis promotion, and tendon/ligament support documented in TCM. Preliminary human BMD data support clinical translation.

• ferulic acidScientific

  Ferulic acid inhibits osteoclastogenesis and bone resorption via RANKL/NF-κB pathway suppression, protecting bone microstructure. In rodent osteoporosis models, FA significantly increased bone mineral density. FA's anti-inflammatory activity reduces cytokine-driven joint and bone destruction. Evidence is currently preclinical.

• fisetinScientific

  Fisetin benefits the musculoskeletal system by reducing bone density loss through senolytic mechanisms in aging models, improving muscle grip strength and frailty in aged mice, and attenuating OA-related joint senescent cell burden.

• fish oilScientific

  Fish oil (EPA and DHA) has robust clinical evidence supporting its role in the musculoskeletal system, particularly for inflammatory joint diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA). Multiple randomized controlled trials and meta-analyses demonstrate reductions in joint pain, morning stiffness, and inflammatory markers. Emerging evidence also supports benefits for skeletal muscle health, including attenuation of exercise-induced muscle damage and mitigation of age-related muscle loss (sarcopenia). Results are most consistent at doses of ≥2.7 g combined EPA+DHA per day.

• forskohlii rootScientific

  A 12-week DBPC RCT in overweight men found significant increases in bone mass measured by DXA, alongside a trend toward increased lean body mass, in the forskolin group versus placebo. cAMP-driven osteoblast stimulation is the proposed mechanism.

• genisteinScientific

  Genistein has well-documented effects on bone mineral density (osteoporosis prevention) and emerging evidence for protection against osteoarthritis and rheumatoid arthritis. Multiple RCTs in postmenopausal women confirm genistein increases bone density and reduces bone resorption markers. Animal and in vitro data support anti-inflammatory and chondroprotective effects relevant to joint health.

• gentiana macrophyllaScientific

  Gentiana macrophylla is one of the primary TCM herbs for musculoskeletal disorders, with preclinical evidence supporting its anti-inflammatory, analgesic, and bone-protective effects. Multiple animal models confirm activity in RA, arthralgia, osteoporosis, and sinew-related conditions. These effects are mediated by gentiopicroside and related iridoid glycosides acting on NF-κB, COX-2, and inflammatory cytokine pathways.

• gingerScientific

  Ginger (Zingiber officinale) has clinical trial evidence supporting its role in musculoskeletal pain relief, including osteoarthritis and exercise-induced muscle soreness. Its bioactive compounds—gingerols, shogaols, and paradols—inhibit COX/LOX inflammatory pathways and NF-κB signaling. A 2015 meta-analysis of five RCTs found statistically significant, though modest, reductions in OA pain and disability. Evidence for delayed onset muscle soreness (DOMS) is also supported by multiple RCTs, but overall evidence quality remains moderate.

• GLA (gamma linolenic acid)Scientific

  GLA has the strongest evidence base among natural supplements for rheumatoid arthritis—a musculoskeletal condition—with multiple RCTs showing significant reduction in joint pain, swelling, and disease activity. Additional evidence exists for bone mineral density preservation in elderly subjects. Typical clinical doses are 1,400–2,800 mg/day for RA.

• glucosamineScientific

  Glucosamine is a naturally occurring building block of cartilage glycosaminoglycans and has been extensively studied for musculoskeletal conditions, primarily knee osteoarthritis (OA). Multiple randomized controlled trials and systematic reviews show that prescription crystalline glucosamine sulfate (1500 mg/day) can modestly reduce pain, improve joint function, and slow joint space narrowing in knee OA. Evidence is formulation-dependent: glucosamine sulfate shows stronger effects than glucosamine hydrochloride, and results across trials remain inconsistent, with NIH/NCCIH noting that overall certainty is still debated.

• glycineScientific

  Glycine is the most abundant amino acid in collagen, constituting roughly one-third of its residues, making it structurally essential for cartilage, bone, tendons, and muscle connective tissue. In vitro and animal studies show that elevated glycine concentrations enhance type II collagen synthesis in chondrocytes, with dietary glycine scarcity identified as a principal cause of collagen misfolding relevant to osteoarthritis. Human clinical evidence supports roles in preserving lean/fat-free mass and improving physical function, particularly in older or malnourished populations, though large-scale RCTs isolating glycine alone remain limited.

• gotu kolaScientific

  Gotu Kola supports musculoskeletal health primarily through anti-inflammatory effects on joints (demonstrated in animal arthritis models) and collagen-stimulating effects on connective tissue. Madecassoside reduced joint inflammation, cartilage erosion, and bone erosion in preclinical rheumatoid arthritis models. Traditional use for rheumatism, arthritis, and joint pain is extensive in Ayurveda and TCM.

• green teaScientific

  Green tea catechins — principally epigallocatechin-3-gallate (EGCG) — have been studied in human clinical trials for their effects on osteoarthritis, rheumatoid arthritis, bone metabolism, and sarcopenia. A randomized clinical trial found green tea extract reduced pain and improved physical function in knee osteoarthritis patients, and a 6-month trial in postmenopausal women with osteopenia showed green tea polyphenols (500 mg/day) improved bone formation markers and muscle strength. Evidence from a rheumatoid arthritis trial also demonstrated improvements in disease activity parameters with green tea supplementation. However, current human evidence remains limited and inconsistent, particularly for hard endpoints like bone mineral density and fracture reduction.

• green-lipped musselScientific

  Green-lipped mussel (GLM; Perna canaliculus) has been investigated in multiple clinical trials and systematic reviews for its effects on osteoarthritis (OA), the most prevalent musculoskeletal condition. A 2021 PRISMA-compliant systematic review of nine clinical trials found that GLM extracts produced moderate, clinically meaningful reductions in OA pain (VAS effect size: −0.46; 95% CI −0.82 to −0.10). Its primary mechanism involves long-chain omega-3 polyunsaturated fatty acids (EPA, DHA, and the rare ETA) that inhibit both COX and LOX inflammatory cascades, suppressing prostaglandin E2 and leukotriene synthesis. Evidence for rheumatoid arthritis is weak, with most clinical trials showing no benefit over placebo.

• guggulScientific

  Guggul's anti-inflammatory and anti-arthritic properties make it relevant to the musculoskeletal system. Both osteoarthritis and rheumatoid arthritis applications are supported by small clinical studies and extensive preclinical data. Ayurvedic formulations like Yogaraj Guggulu and Simhanada Guggulu are specifically designed for musculoskeletal conditions.

• harpagosideScientific

  Harpagoside, the primary iridoid glycoside marker compound in Harpagophytum procumbens (devil's claw), has well-documented anti-inflammatory and analgesic effects relevant to the musculoskeletal system. Clinical evidence from multiple RCTs and systematic reviews supports its use for non-specific low back pain and osteoarthritis of the spine, hip, and knee. Its mechanism involves suppression of NF-κB activation, with downstream inhibition of COX-2, iNOS, and pro-inflammatory cytokines. The European Medicines Agency (EMA/HMPC) has recognized devil's claw for joint pain relief.

• hesperetinScientific

  Hesperetin has shown chondroprotective and anti-inflammatory effects relevant to musculoskeletal health. In preclinical studies it protects chondrocytes via the AMPK-NF-κB pathway, and an RCT in cyclists demonstrated modulation of exercise-induced inflammatory and oxidative stress markers.

• hesperidinScientific

  Hesperidin supports the musculoskeletal system through promotion of osteogenesis, improvement of bone microarchitecture, enhancement of bone turnover markers, inhibition of pro-inflammatory bone resorption, and protection of collagen in tendons and ligaments. Clinical trial NCT01881204 evaluated hesperidin with calcium for bone health in postmenopausal women.

• HMB hydroxymethylbutyrateScientific

  HMB (β-hydroxy-β-methylbutyrate), a metabolite of the amino acid leucine, has substantial clinical evidence supporting its role in preserving and building skeletal muscle mass, improving muscle strength, and attenuating muscle wasting. Multiple randomized controlled trials and meta-analyses demonstrate statistically significant, though modest, benefits for muscle strength (SMD ≈ 0.31) and some evidence for muscle mass gains, particularly in older adults, wasting conditions, and exercise contexts. The standard researched dose is 3 g/day, and HMB has a strong safety profile across clinical populations.

• hopsScientific

  8-PN from hops protects against estrogen-depletion-induced bone loss in murine models via estrogenic anti-resorptive mechanisms. A product containing hops iso-alpha acids was evaluated in a pilot RCT in arthritis and fibromyalgia patients, reducing CRP. Hops' estrogenic and anti-inflammatory activities both support musculoskeletal relevance.

• horsetailScientific

  Horsetail has a well-established relationship with the musculoskeletal system, primarily through its exceptional silica content supporting bone formation, collagen synthesis, and connective tissue integrity. Small human clinical trials support improvements in bone mineral density, and the European Pharmacopoeia recognizes its use for bone and connective tissue health. Preclinical studies further confirm osteoblast stimulation and osteoclast inhibition.

• hyaluronic acidScientific

  Hyaluronic acid (HA) is a naturally occurring biopolymer central to synovial fluid, providing lubrication and shock absorption in joints. Intra-articular HA injections (viscosupplementation) are an FDA-recognized treatment for knee osteoarthritis, supported by multiple RCTs and systematic reviews showing small but statistically significant improvements in pain and function. Oral HA supplementation at 30–300 mg/day also shows emerging clinical evidence of benefit for joint pain and stiffness, though results are more variable.

• impatiensScientific

  Traditional use of Impatiens for rheumatism, bruises, fractures, lumbago, and general musculoskeletal pain is extensively documented. Preclinical studies confirm antinociceptive and anti-inflammatory effects in relevant animal models including a rheumatoid arthritis model and a carrageenan paw edema model.

• indian frankincenseScientific

  The musculoskeletal system is the best-evidenced domain for Boswellia serrata, with clinical RCTs in OA, RA, and spinal inflammatory conditions demonstrating significant reductions in pain, swelling, and stiffness and improvements in physical function. A meta-analysis of 7 OA trials (n=545) confirmed positive outcomes across the system.

• ipriflavoneScientific

  Ipriflavone exerts well-documented direct effects on the skeletal compartment of the musculoskeletal system, inhibiting osteoclast-mediated bone resorption and stimulating osteoblast production and activity. Dozens of RCTs over more than three decades have investigated its effects on bone mineral density across postmenopausal osteoporosis, surgical menopause, steroid-induced bone loss, immobilization, and renal osteodystrophy. It is approved as a prescription drug for osteoporosis in several countries.

• isoleucineScientific

  Isoleucine is concentrated primarily in muscle tissue and is essential for muscle protein metabolism, structural integrity, and repair of the musculoskeletal system. BCAA supplementation including isoleucine has been shown in RCTs to improve muscle mass, strength, and function, and cross-sectional studies link isoleucine intake to lower sarcopenia risk in older adults.

• kaleScientific

  Kale provides calcium, vitamin K1, magnesium, and vitamin C—nutrients required for bone matrix formation, muscle contraction, and connective tissue integrity. Vitamin K1 activates osteocalcin and matrix Gla protein for bone mineralization. Combined vitamin K and calcium supplementation in RCTs shows modest positive effects on lumbar bone mineral density.

• krill oilScientific

  Krill oil delivers phospholipid-bound EPA and DHA that act as precursors to specialized pro-resolving mediators, attenuating joint inflammation relevant to musculoskeletal conditions such as osteoarthritis. Multiple RCTs and two recent meta-analyses (2025–2026) support statistically significant improvements in knee pain and physical function scores, though effect sizes are moderate and evidence for structural OA modification remains limited. Dosing studied in trials ranges from 2–4 g/day over 4–24 weeks.

• kudzuScientific

  Kudzu has TCM applications for musculoskeletal complaints including stiff neck, muscle tension, and joint inflammation. Clinical evidence in humans demonstrates reductions in bone resorption and cartilage degradation markers in menopausal women. Puerarin's anti-inflammatory effects are also relevant to muscle and joint health.

• L-alanineScientific

  Skeletal muscle is the primary site of L-alanine synthesis during exercise and fasting, making it a central player in musculoskeletal fuel management. Muscle releases alanine into the circulation to export nitrogen and provide the liver with gluconeogenic substrate, thereby sustaining glucose supply back to the muscle itself.

• l-carnitineScientific

  L-carnitine supports skeletal muscle energy metabolism and has been studied for exercise recovery, muscle damage, and age-related sarcopenia. An 8-week RCT in older adults showed significant improvements in muscle mass and strength. L-carnitine increases total antioxidant capacity and reduces markers of muscle damage post-exercise.

• L-carnosineScientific

  Skeletal muscle contains the highest concentration of carnosine of any tissue. L-carnosine/beta-alanine supplementation demonstrably increases muscle carnosine, improving pH buffering capacity, reducing fatigue, and attenuating sarcopenia. RCTs and systematic reviews confirm benefits for muscle performance in athletes and elderly populations.

• L-glutamineScientific

  L-glutamine is the most abundant amino acid in skeletal muscle and is released in large quantities after exercise-induced damage. RCTs show supplementation attenuates strength loss and muscle soreness following eccentric exercise, and supports nitrogen balance in catabolic states.

• L-glycineScientific

  Glycine is the dominant amino acid in all musculoskeletal connective tissues—constituting one-third of collagen in bone, cartilage, tendons, ligaments, and muscle fascia. It is rate-limiting for collagen synthesis across all these tissues. GlyNAC clinical trials show improvements in muscle strength and gait speed in older adults, and collagen supplement RCTs demonstrate benefits for joint function and muscle connective protein synthesis.

• l-isoleucineScientific

  As a BCAA primarily metabolized in skeletal muscle, L-isoleucine contributes to muscle protein synthesis, suppression of muscle protein breakdown, and recovery from exercise-induced damage. Human RCTs demonstrate BCAAs including isoleucine activate mTOR signaling in muscle and transiently increase myofibrillar protein synthesis rates. The musculoskeletal relevance is strongest in the context of exercise recovery.

• L-leucineScientific

  Leucine is the principal amino acid regulator of skeletal muscle protein synthesis, acting via mTORC1 to drive translational initiation and inhibit proteolysis. A systematic review and meta-analysis of 17 RCTs confirmed functional improvements in sarcopenic elderly adults. Leucine also plays roles in bone mineral-free lean tissue mass and muscle proteolysis suppression, making it the most studied amino acid for musculoskeletal preservation.

• L-prolineScientific

  L-Proline is a biochemically essential substrate for collagen synthesis, and collagen constitutes the primary structural protein of bone, cartilage, tendon, and ligament. Proline residues must be hydroxylated by prolyl hydroxylase enzymes (requiring vitamin C) to stabilize the collagen triple helix at physiological temperature. In vitro evidence confirms that proline availability directly limits collagen output in chondrocytes, with potential implications for cartilage maintenance and osteoarthritis. No standalone clinical RCTs on isolated L-proline supplementation in humans exist, though the mechanistic and preclinical evidence base is well-established.

• L-valineScientific

  L-Valine is required for muscle protein synthesis and is metabolized directly in skeletal muscle. Multiple human clinical trials and large-scale epidemiological studies associate valine levels with muscle mass and strength. BCAA supplementation including valine has shown benefits for sarcopenia, post-exercise recovery, and post-surgical muscle preservation in multiple RCTs.

• lactobacillus rhamnosusScientific

  L. rhamnosus GG protects musculoskeletal health primarily through the gut-bone axis, modulating immune cell balance (Th17/Treg), reducing bone resorption markers, and improving trabecular bone microarchitecture in preclinical models. Enhanced GLUT4 in skeletal muscle (insulin sensitivity) and adiponectin effects also have musculoskeletal relevance.

• lactoferrinScientific

  Lactoferrin acts directly on bone metabolism by stimulating osteoblast proliferation and suppressing osteoclast activity, supported by strong preclinical evidence and emerging human biomarker data. It also has potential roles in joint inflammation through cytokine modulation. Most human evidence focuses on bone turnover markers rather than structural endpoints.

• lignansScientific

  Lignans may support musculoskeletal health through phytoestrogenic interactions with ERβ on osteoblasts and via anti-inflammatory actions. Flaxseed lignans during exercise training in individuals aged 50+ have shown reductions in metabolic syndrome parameters relevant to bone and muscle health, including inflammatory cytokines. Preclinical and some clinical evidence supports a role in bone mineral density preservation.

• macaScientific

  Maca has demonstrated benefits for the musculoskeletal system primarily through bone-protective effects (preventing estrogen-deficient bone loss in animal models) and anti-fatigue/muscle-recovery effects via antioxidant activity in exercise models. Traditional use also includes bone and joint support.

• magnesiumScientific

  Magnesium has well-documented, clinically studied roles in the musculoskeletal system, including bone mineralisation, skeletal muscle contraction, and connective tissue integrity. It is a cofactor for over 300 enzymes, governs calcium flux in muscle and bone cells, and modulates parathyroid hormone activity. A systematic review and meta-analysis found that higher magnesium intake is associated with increased hip and femoral neck bone mineral density in older adults. Clinical evidence also shows magnesium supplementation can reduce muscle soreness, improve exercise recovery, and support muscle mass preservation, particularly in ageing populations.

• manganeseScientific

  Manganese is required as a cofactor for glycosyltransferases that synthesize proteoglycans and glycosaminoglycans—the structural molecules of cartilage and bone matrix. Deficiency impairs bone formation, reduces mineral density, and compromises cartilage integrity.

• melatoninScientific

  Melatonin exerts receptor-dependent and receptor-independent effects across the entire musculoskeletal system, including bone, cartilage, skeletal muscle, tendons, and intervertebral discs. Clinical evidence supports improvements in BMD in postmenopausal women, while preclinical and translational data document cartilage protection, muscle regeneration support, and attenuation of exercise-induced damage.

• menthol oilScientific

  Topical menthol is FDA-approved as an OTC counterirritant for musculoskeletal pain and has evidence from RCTs for muscle strain, DOMS, joint pain, and arthritis. It is among the best-documented herbal/natural topical analgesics for musculoskeletal conditions.

• millet seedScientific

  Millet provides calcium, phosphorus, and magnesium essential for bone matrix formation and density. Clinical trials in premenopausal women show finger millet supplementation significantly improves BMD and serum calcium. Millet proteins are also a source of essential amino acids contributing to muscle tissue maintenance.

• morindaScientific

  Morinda officinalis is classified in TCM as 'strengthening tendons and bones' and 'dispelling wind-dampness,' directly targeting the musculoskeletal system. Modern evidence confirms osteogenic, anti-arthritic, analgesic, and antifatigue activities in animal models, with the osteogenic mechanism characterised to BMP-SMAD/NF-κB pathway level.

• MSM (methylsulfonylmethane)Scientific

  MSM (Methylsulfonylmethane) has been evaluated in multiple randomized, double-blind, placebo-controlled trials primarily for knee osteoarthritis, with results showing statistically significant improvements in pain and physical function at doses of approximately 3–6 g/day over 12 weeks. Systematic reviews characterize the evidence as positive but not definitive, with small trial sizes and short durations limiting conclusions. Additional research suggests MSM may attenuate post-exercise musculoskeletal pain, though effect sizes have not reached clinical significance in meta-analyses.

• mugwortScientific

  A. vulgaris demonstrates anti-inflammatory and analgesic activity in multiple rodent models relevant to musculoskeletal pain and inflammation. Moxibustion is clinically studied for osteoarthritis and low-back pain. Vietnamese traditional medicine uses A. vulgaris for arthritis and gout, with xanthine oxidase inhibitory activity confirmed in vitro.

• myristoleateScientific

  CMO's clinical evidence spans multiple musculoskeletal conditions: osteoarthritis, rheumatoid arthritis, fibromyalgia, and low back pain. Beyond joints, it is proposed to act as a lubricant for muscles and connective tissues more broadly. A combination composition patent for joint and muscle inflammation specifically names CMO as the cetylated fatty acid of choice.

• myrrhScientific

  Myrrh demonstrates significant analgesic and anti-inflammatory activity in musculoskeletal pain models. Animal studies confirm efficacy in writhing, hot plate, and formalin models comparable to reference NSAIDs. Traditional Chinese medicine uses myrrh-containing formulations for arthritis, trauma, and musculoskeletal pain.

• N-acetyl-glucosamineScientific

  NAG provides biosynthetic substrates (GAGs, HA, chondroitin sulfate) for cartilage, tendons, ligaments, and synovial fluid. Human clinical evidence shows beneficial changes in cartilage metabolism biomarkers with oral NAG supplementation, and preclinical data support reduced joint inflammation and improved tissue healing.

• naringinScientific

  Naringin promotes osteoblast differentiation, inhibits osteoclastogenesis, improves BMD, and protects against disuse and postmenopausal osteoporosis in animal models. A meta-analysis of 10 OVX rat studies showed significant BMD improvement. Anti-inflammatory effects may also benefit joint and muscle health indirectly. Naringin is a traditional TCM ingredient for bone fractures.

• nettleScientific

  Nettle (Urtica dioica) has documented clinical evidence supporting its use for musculoskeletal conditions including osteoarthritis, rheumatoid arthritis, and general joint pain. Multiple human trials—including randomized controlled studies—have demonstrated reductions in pain, disability, and inflammatory markers. The primary mechanism identified is inhibition of the pro-inflammatory transcription factor NF-κB, suppressing downstream cytokines such as TNF-α and IL-1β in synovial tissue. Evidence quality is promising but overall trial sizes remain small, and larger definitive RCTs are still needed.

• nicotinamide ribosideScientific

  NR augments the skeletal muscle NAD+ metabolome in aged humans and has been tested for effects on muscle regeneration, sarcopenia, and walking capacity in elderly and PAD populations. A randomized trial in 90 PAD patients assessed walking distance and skeletal muscle mitochondrial outcomes. Preclinical evidence shows NR rescues NAMPT-depletion-induced sarcopenia in mice via sirtuin-dependent mechanisms.

• NMN (β-nicotinamide mononucleotide)Scientific

  NMN has been studied in the context of muscle mass, grip strength, lower limb function, aerobic capacity, and skeletal muscle insulin sensitivity in human RCTs. Results show improvements in endurance and some functional measures, particularly in older adults and at higher doses.

• oleanolic acidScientific

  OA benefits the musculoskeletal system through its bone-protective effects (increasing BMD, modulating vitamin D metabolism), anti-arthritic effects in synovial tissue (suppressing COX-2, MMP3, NF-κB in fibroblast-like synoviocytes), and analgesic properties relevant to musculoskeletal pain.

• oliveScientific

  Olive polyphenols support the musculoskeletal system through anti-inflammatory effects on joints, bone-forming effects via osteoblast stimulation, and preliminary clinical evidence for osteoarthritis pain relief and bone density support in postmenopausal women. The strongest human data are from the bone osteocalcin trial and ex-vivo RA cell work.

• olive oilScientific

  Olive oil supports musculoskeletal health by preserving bone mineral density, reducing joint inflammation, and protecting muscle function. Human cross-sectional data link olive oil intake to better bone density. A 2025 clinical study found olive oil improved muscle strength more than soybean oil in diabetic patients.

• omega-3 fatty acidsScientific

  Omega-3 fatty acids (EPA and DHA) have substantial human clinical evidence supporting their role in musculoskeletal health across three domains: inflammatory joint disease, skeletal muscle mass and function, and bone metabolism. The strongest evidence is in rheumatoid arthritis, where multiple RCTs and reviews consistently show reductions in joint pain, morning stiffness, and tender/swollen joint counts. Evidence for osteoarthritis pain relief and sarcopenia prevention is present but more modest and mixed. Overall, the evidence base is scientific but effect sizes are often small-to-moderate and consistency varies by outcome and population.

• omega-6 fatty acidsScientific

  Arachidonic acid (AA), a long-chain omega-6 PUFA, is present at high concentrations in skeletal muscle phospholipids (up to 25% of fatty acid content) and plays a signaling role in muscle repair and recovery. GLA-rich omega-6 supplements have RCT evidence in inflammatory joint diseases (RA). AA supplementation (1.5 g/day) increased muscle AA content and showed potential benefit for muscle performance without adverse effects on inflammation.

• onionScientific

  Onion supports musculoskeletal health through anti-osteoporotic effects on bone and anti-inflammatory effects relevant to joint and muscle health. Onion flavonoid extract doubles bone mineral density in animal models through dual mechanisms of osteoblast stimulation and osteoclast inhibition. The quercetin content addresses both arthritic joint inflammation and bone resorption.

• palm oilScientific

  Palm tocotrienols protect the musculoskeletal system by improving bone mineral density, reducing bone resorption, protecting joint cartilage, and facilitating fracture healing in preclinical models. A human RCT confirmed tocotrienol supplementation reduces bone resorption biomarkers in postmenopausal osteopenic women. The mechanism involves antioxidant suppression of osteoclast-activating oxidative stress.

• parsleyScientific

  Parsley's exceptional vitamin K content activates bone matrix proteins (osteocalcin, MGP) essential for skeletal mineralisation. Its folate reduces homocysteine, which increases fracture risk when elevated. Anti-inflammatory flavonoids may also reduce musculoskeletal inflammation. Vitamin K's role in bone health is well-supported by clinical evidence.

• partheniumScientific

  Feverfew has documented use and mechanistic evidence for musculoskeletal applications, primarily through anti-inflammatory and antinociceptive actions relevant to joint disease, rheumatoid arthritis, and musculoskeletal pain. One RCT showed significantly improved grip strength in RA patients. Animal studies demonstrate dose-dependent anti-inflammatory effects in oedema models.

• peaScientific

  Human RCTs confirm pea protein supplementation combined with resistance training improves whole-body muscle strength and muscle mass in sedentary adults, with effects equivalent to whey protein. Pea protein supports muscle protein synthesis due to its complete essential amino acid profile.

• phellodendron amurenseScientific

  P. amurense has been evaluated in human RCTs for osteoarthritis of the knee, showing improvements in joint pain, function scores, and inflammatory biomarkers. Berberine and palmatine from P. amurense are reviewed as having bone-protective properties and having undergone small clinical trials improving bone density in postmenopausal women. TCM uses P. amurense for joint pain, arthritis, and lower limb weakness.

• phosphorusScientific

  Phosphorus, together with calcium, forms hydroxyapatite—the mineral matrix of bone and tooth enamel. Adequate phosphorus is essential for bone growth and mineralization; both deficiency (rickets, osteomalacia) and excess intake cause distinct bone pathology. Serum phosphorus is associated with bone mineral density.

• pine barkScientific

  Pine bark extract (primarily as Pycnogenol®) has been investigated in multiple human clinical trials for osteoarthritis, the most studied musculoskeletal application. Three double-blind, randomized, placebo-controlled trials demonstrated statistically significant reductions in WOMAC scores (pain, stiffness, daily activities) at doses of 100–150 mg/day over three months. Mechanistic studies confirm that the extract's polyphenols reach synovial fluid and downregulate key cartilage-degradation markers. Overall evidence is preliminary and limited by small sample sizes and industry involvement.

• pineappleScientific

  Bromelain is among the most studied natural compounds for musculoskeletal conditions, with clinical evidence in osteoarthritis, rheumatoid arthritis, sports injuries, post-surgical swelling, and muscle recovery. Pineapple's manganese supports bone and connective tissue enzyme systems.

• pomegranateScientific

  Pomegranate supports musculoskeletal health by reducing exercise-induced muscle damage, lowering inflammatory markers in arthritis, and exhibiting chondroprotective effects. RCTs in athletes and RA/OA patients form the clinical basis. Phytoestrogen and antioxidant content may also support bone and cartilage in peri/postmenopausal women.

• potassiumScientific

  Potassium is essential to skeletal muscle contraction, membrane excitability, and bone mineral density. It underpins the electrochemical gradients required for muscle action potentials and moderates acid-induced calcium efflux from bone. Clinical evidence spans exercise physiology studies and bone density trials.

• pregnenoloneScientific

  Pregnenolone's downstream hormones — including DHEA, testosterone, and cortisol — directly regulate muscle mass, bone density, and connective tissue integrity. Its analgesic efficacy in a chronic musculoskeletal pain RCT (JAMA Network Open 2020) provides direct clinical evidence of musculoskeletal relevance.

• prickly ashScientific

  Prickly ash has preclinical evidence (rodent models of arthritis and inflammatory pain) and extensive traditional documentation for musculoskeletal applications including rheumatism, joint pain, and muscle pain. The 2024 PMC Frontiers review and multiple preclinical studies support anti-inflammatory and analgesic effects on musculoskeletal tissue. It is classified as 'antirheumatic' in professional herbal monographs.

• privetScientific

  Preclinical animal data consistently demonstrate FLL improves bone mineral density, bone microarchitecture, and calcium metabolism in models of osteoporosis and aging. The 2020 Chinese Pharmacopoeia recognizes invigorating muscles and bones as core functions. TCM use for bone pain and rheumatic conditions spans over 1,000 years.

• pruneScientific

  Prune consumption is among the most evidence-supported dietary interventions for musculoskeletal health, specifically bone mineral density preservation in postmenopausal women. Phenolic compounds suppress osteoclast activity and promote osteoblast differentiation, while anti-inflammatory effects reduce bone-resorbing cytokines. Evidence includes two positive human RCTs and 16 preclinical studies.

• pycnogenolScientific

  Multiple randomized controlled trials demonstrate that Pycnogenol (French maritime pine bark extract) reduces pain, stiffness, and functional impairment in knee and hand osteoarthritis (OA). Mechanistically, it inhibits NF-κB activation, suppresses matrix metalloproteinases (MMPs), and downregulates COX-2 and pro-inflammatory cytokines in joint tissues. A 2017 RCT confirmed that Pycnogenol constituents distribute into synovial fluid and exert measurable chondroprotective effects at the cellular level. However, a meta-analysis cited by Memorial Sloan Kettering Cancer Center recommended against Pycnogenol for musculoskeletal pain, and broader systematic reviews note that existing trials are small and that large-scale confirmatory studies are still needed.

• queen of the meadowScientific

  Queen of the meadow has pre-clinical scientific evidence for musculoskeletal benefit through COX inhibition, anti-inflammatory activity in animal joint models, and analgesic effects in multiple pain models. The EMA formally recognizes it as a traditional product for minor joint pain. Pharmacological properties relevant to musculoskeletal conditions are among its best-documented activities.

• quercetinScientific

  Quercetin, a polyphenolic flavonoid, has documented scientific evidence supporting its role in musculoskeletal health across bone, muscle, cartilage, and tendon tissues. Human randomized controlled trial (RCT) data show it significantly reduces exercise-induced muscle damage and soreness. Preclinical evidence further supports chondroprotective, osteogenic, and anti-sarcopenic effects, though robust human clinical trials for bone and joint endpoints remain limited and ongoing.

• quinoaScientific

  Quinoa is a complete protein providing all essential amino acids for muscle tissue synthesis and repair. Its manganese, phosphorus, magnesium, and calcium content supports bone matrix formation and maintenance. Germination significantly increases mineral availability. Dietetic guidelines recommend quinoa for bone density support in celiac disease. Its complete protein profile is recognized as beneficial for muscle protein synthesis in plant-based diets.

• red cloverScientific

  Red clover isoflavones have been clinically studied for bone mineral density preservation in postmenopausal women, representing the primary musculoskeletal evidence. Arthritis, gout, and joint pain are traditional indications with anti-inflammatory mechanistic support but no dedicated RCT evidence. The bone density evidence is scientifically grounded across multiple trials.

• rehmanniaScientific

  Rehmannia exerts documented effects on bone density, cartilage integrity, and joint inflammation relevant to the musculoskeletal system. It increases osteoblastogenesis, reduces osteoclastogenesis, inhibits osteoarthritis cartilage degradation, and suppresses arthritic inflammation through NF-κB, Th17, and TGF-β pathways. Clinical pharmacological reviews confirm its use for osteoporosis.

• rehmannia glutinosaScientific

  R. glutinosa has documented effects on bone metabolism (BMD, osteoblasts, osteoclasts) and has been used in TCM for joint diseases and bone loss for centuries. Multiple preclinical studies confirm anti-osteoporotic effects, and clinical use in over 107 osteoporosis studies (co-prescriptions) is documented.

• resveratrolScientific

  Resveratrol has documented clinical (human) evidence supporting its role in musculoskeletal health, spanning bone mineral density, osteoarthritis, and skeletal muscle. Multiple randomized controlled trials have tested resveratrol in postmenopausal women, obese men with metabolic syndrome, and osteoarthritis patients, with generally positive but inconsistent results. Mechanistically, resveratrol acts via SIRT1 activation, anti-inflammatory pathways, and phytoestrogenic activity to modulate bone remodeling and cartilage protection. Clinical evidence is promising but not yet sufficient to establish firm therapeutic recommendations.

• rose hipsScientific

  Rose hip has the strongest and most replicated clinical evidence base for musculoskeletal benefits: multiple RCTs demonstrate significant pain and stiffness reduction in osteoarthritis. Anti-inflammatory galactolipids and polyphenols inhibit COX-1/2, reduce inflammatory cytokines, and protect cartilage matrix. A meta-analysis of three RCTs (n=287) found pain improvement at roughly 2:1 over placebo.

• rutinScientific

  Rutin reduces inflammatory markers and arthritic signs in joint disease models, supports collagen synthesis in bone and connective tissue, and protects muscle against sarcopenic loss through antioxidant and anti-inflammatory mechanisms. Evidence spans human macrophage data, animal arthritis models, and a rabbit bone repair study.

• safflowerScientific

  Safflower seeds are used in Korean and Chinese traditional medicine to promote bone formation and prevent osteoporosis. A PubMed-indexed study investigated safflower seeds in ovariectomized rats and found reduction of bone loss and trabecular bone mass preservation. HSYA inhibits osteoclast differentiation and bone resorption by inhibiting carbonic anhydrase 2 activity in a rat osteoporosis model. Safflower also has traditional and preclinical anti-inflammatory applications for rheumatism, sciatica, and muscle pain.

• salicinScientific

  The musculoskeletal system is the primary evidence-supported target of salicin. Clinical trials in low back pain and osteoarthritis, plus the NCCIH and German Commission E designations, all converge on musculoskeletal pain and inflammation as the best-validated application of salicin-containing preparations.

• SAMe (S-adenosyl-L-methionine)Scientific

  SAMe has been studied in multiple randomized controlled trials and a Cochrane systematic review for its role in managing osteoarthritis symptoms, particularly joint pain and stiffness. Proposed mechanisms include stimulation of chondrocyte proteoglycan synthesis, reduction of inflammatory mediators, and maintenance of cartilage matrix integrity. While clinical trials show pain and functional benefits broadly comparable to NSAIDs, the Cochrane review characterizes the overall evidence as low-to-moderate quality, calling for larger, better-designed trials before routine use is recommended.

• sarsaparillaScientific

  Sarsaparilla has preclinical evidence of anti-inflammatory and analgesic activity directly relevant to muscles and joints. Traditional use for rheumatism, arthritis, and joint pain is universal across herbal systems. Animal studies confirm reduction of inflammatory mediators in musculoskeletal models. Human evidence is limited to a case report.

• schizonepetaScientific

  The 2016 BMC study demonstrated EEST inhibits osteoclastogenesis and protects against inflammatory bone loss in animals, directly supporting musculoskeletal relevance. Anti-inflammatory mechanisms relevant to arthritis are also well-documented preclinically. No human musculoskeletal trials exist.

• secoisolariciresinol diglucosideScientific

  SDG protects musculoskeletal integrity by acting as a phytoestrogen on bone estrogen receptors to prevent postmenopausal osteoporosis, and by suppressing NF-κB and activating Nrf2/HO-1 to reduce cartilage degradation in osteoarthritis models. Clinical evidence confirms SDG increases bone mass and serum calcium in postmenopausal women. In vivo OA models showed SDG alleviated cartilage degeneration.

• serrapeptaseScientific

  Serrapeptase, a proteolytic enzyme derived from Serratia bacteria, has been clinically evaluated in orthopaedic and musculoskeletal contexts for its anti-inflammatory, anti-edemic, and analgesic properties. Human trials exist for conditions including ankle sprains, carpal tunnel syndrome, and osteoarthritis of the knee, though overall evidence quality is rated low to moderate. A 2013 systematic review concluded that existing scientific evidence is insufficient to firmly support its use as an analgesic, and more recent analyses concur that it is not a highly effective supplement for joint health and inflammation.

• serratiopeptidaseScientific

  Serratiopeptidase has established clinical use in orthopedics for traumatic swelling, sports injuries, osteoarticular infection, carpal tunnel syndrome, arthritis, and back pain. Multiple clinical trials across these orthopedic indications are documented in the Bhagat 2013 systematic review. It is prescribed by orthopedic surgeons in Japan, Europe, and India for musculoskeletal inflammation and pain.

• sesameScientific

  Sesame has documented effects on bone density (mineral-rich; calcium, zinc, copper content supporting bone matrix), osteoarthritis (clinical trial in knee OA showing reduced MDA and hs-CRP), and joint inflammation (sesamol inhibiting TNF-α, IL-1β, COX-2, MMPs). Phytoestrogenic lignans may slow postmenopausal bone resorption. Evidence spans human clinical trials and well-characterized mechanistic data.

• shark cartilageScientific

  Shark cartilage has been used since the 1950s as a supplement for musculoskeletal conditions, particularly osteoarthritis and rheumatoid arthritis, due to its content of chondroitin sulfate, type II collagen, and proteoglycans. Its key bioactive components have documented anti-inflammatory mechanisms and have been tested in preclinical and some clinical settings. However, evidence specific to whole shark cartilage in humans remains inconsistent and limited, with stronger evidence existing for its isolated constituents (chondroitin sulfate, type II collagen) than for the crude supplement itself.

• shea butterScientific

  Shea nut oil triterpene concentrate has demonstrated reduction of osteoarthritis development and joint destruction in a rat surgical model, providing preclinical evidence for musculoskeletal benefits. Traditional use for muscle pain, rheumatism, and arthritis across Sub-Saharan Africa is extensively documented.

• shiitake mushroomScientific

  Shiitake's vitamin D2 content supports calcium absorption essential for bone and muscle function. Copper and zinc in shiitake are required cofactors for bone matrix synthesis. A Cochrane Library-indexed human study examined shiitake extract's effect on antioxidant and inflammatory responses to prolonged eccentric exercise, with attenuated inflammation post-exercise. UV-irradiated shiitake raised 25(OH)D2 in humans, supporting musculoskeletal vitamin D status.

• siler rootScientific

  SD has multiple preclinical studies supporting anti-inflammatory and analgesic effects relevant to musculoskeletal conditions, including osteoarthritis and rheumatoid arthritis animal models. Chromone extract reduced joint inflammation markers, improved weight-bearing, and protected cartilage. The Chinese Pharmacopoeia lists arthralgia and rheumatic disease among official indications.

• siliconScientific

  Dietary silicon, primarily as orthosilicic acid (OSA), has well-documented roles in supporting musculoskeletal health, particularly bone mineral density and connective tissue integrity. Human cohort studies show significant positive associations between silicon intake and bone mineral density, and at least one randomized controlled trial demonstrates that silicon supplementation stimulates markers of bone formation in osteopenic women. Mechanistically, silicon promotes type I collagen synthesis, osteoblastic differentiation, and the cross-linking of collagen with proteoglycans in bone matrix.

• silymarinScientific

  Silymarin demonstrates osteogenic activity in preclinical studies, promoting osteoblast differentiation, alkaline phosphatase expression, and bone mineral density in animal models. Anti-inflammatory properties are relevant to inflammatory arthritis and muscle inflammation. Pro-estrogenic receptor activity provides mechanistic relevance to postmenopausal musculoskeletal loss.

• soyScientific

  Soy isoflavones have documented effects on the musculoskeletal system through their phytoestrogenic action on bone, supported by meta-analyses showing modest but significant BMD improvements at lumbar spine in menopausal women. Soy protein also provides amino acids for muscle maintenance. Bone resorption markers are reduced.

• soy isoflavonesScientific

  Soy isoflavones have been studied extensively for bone health, with a meta-analysis of 52 RCTs showing significant improvements in lumbar spine, hip, and femoral neck BMD. Effects on bone resorption markers are also documented.

• soybeanScientific

  Soy isoflavones have documented effects on the musculoskeletal system, primarily through preservation of bone mineral density in postmenopausal women via phytoestrogenic activity. Multiple meta-analyses of RCTs confirm significant improvements in lumbar spine BMD. Animal studies and some clinical data also suggest anti-inflammatory effects of isoflavones protect bone and potentially muscle from chronic inflammation-driven tissue loss.

• spinachScientific

  Spinach vitamin K1 activates osteocalcin for bone mineralisation; RCTs show vitamin K reduces fracture risk. A 12-week RCT of spinach extract in adults >50 during resistance training improved muscle strength, muscle quality, and body composition, supporting both bone and muscle components of musculoskeletal health.

• SPMs (specialized pro-resolving mediators)Scientific

  SPMs are produced in and act on multiple musculoskeletal tissues including joints, bones, muscles, and tendons. Human biomarker data (synovial fluid, alveolar bone), preclinical efficacy studies, and human interventional trials collectively establish the musculoskeletal system as a major SPM target.

• strontiumScientific

  Strontium, principally as strontium ranelate, has robust clinical evidence supporting its role in treating osteoporosis — a disease of the musculoskeletal system. Multiple Phase III randomized controlled trials demonstrated significant reductions in vertebral and non-vertebral fractures in postmenopausal women. The EMA approved strontium ranelate for severe osteoporosis, though its use has been restricted due to cardiovascular safety concerns. Strontium citrate, a supplement form, lacks equivalent fracture-prevention evidence.

• taurineScientific

  Taurine is one of the most abundant amino acids in skeletal and cardiac muscle, where it regulates calcium homeostasis, membrane excitability, and mitochondrial energy production. It reduces exercise-induced oxidative stress and has been studied for improving exercise capacity in heart failure patients.

• teaselScientific

  The musculoskeletal system is the primary therapeutic target of teasel root across both TCM and modern preclinical research, encompassing bone, joint, tendon, and muscle applications. Multiple animal and in vitro studies confirm osteogenic, anti-arthritic, and analgesic activities relevant to the musculoskeletal system.

• tinospora cordifoliaScientific

  T. cordifolia demonstrates anti-arthritic, anti-osteoporotic, and bone-protective effects across multiple preclinical models. It suppresses joint inflammation via cytokine reduction, promotes osteoblast differentiation, and prevents bone loss in ovariectomized rats. Ayurvedic texts cite it for rheumatoid arthritis and musculoskeletal disorders.

• tocotrienolsScientific

  Preclinical evidence strongly supports tocotrienol bone protection through osteoblast promotion and osteoclast inhibition. Epidemiological data link vitamin E intake to bone density preservation. In vitro human bone cell data and multiple animal osteoporosis models are consistent; dedicated human RCTs are underway but not yet published.

• tomatoScientific

  Lycopene from tomatoes supports bone health through activation of osteogenic signaling pathways and suppression of bone resorption. A pilot clinical study in postmenopausal women demonstrated bone density preservation with daily tomato sauce consumption. Epidemiological data links lycopene intake to lower fracture risk.

• tongkat aliScientific

  Clinical studies show Tongkat Ali increases muscular force and lean body mass in aging adults and exercising individuals, mediated by testosterone elevation. A pilot study in seniors found significant increases in muscular force alongside testosterone. Preclinical data additionally show anti-osteoporotic activity via osteoblast enhancement and prevention of bone calcium loss. Human evidence for bone effects is not yet established in clinical trials.

• trans-geranylgeraniolScientific

  GGOH has dual mechanistic relevance to the musculoskeletal system: it supports skeletal muscle cell viability, differentiation, and protein prenylation while simultaneously promoting osteoblast activity and suppressing osteoclastogenesis. Multiple peer-reviewed studies in human and rodent cell models confirm these effects. Statin-induced GGOH depletion is the leading preclinical explanation for statin-associated myopathy.

• trypsinScientific

  Trypsin:chymotrypsin preparations have a well-documented clinical evidence base for musculoskeletal indications including orthopedic surgical injuries, sprains, fractures, and osteoarthritis. Multiple RCTs and a systematic review support their anti-inflammatory, analgesic, and anti-edematous effects in this system. They have been used clinically since the 1960s.

• turmericScientific

  Turmeric, via its active polyphenol curcumin, has meaningful clinical evidence supporting its use for musculoskeletal conditions—particularly osteoarthritis. Multiple randomized controlled trials and systematic reviews confirm reductions in joint pain and improvements in physical function, with effects in knee OA comparable to NSAIDs in some analyses. The mechanistic basis involves suppression of NF-κB, COX-2, and pro-inflammatory cytokines that drive cartilage degradation and joint inflammation. Evidence quality is moderate; bioavailability limitations and heterogeneous formulations remain active research challenges.

• urolithin aScientific

  UA has the most extensive human clinical evidence for effects on the musculoskeletal system, with multiple RCTs demonstrating improvements in muscle strength, endurance, and exercise performance. Additionally, preclinical data with human cell models show benefits for cartilage and joint health in the context of osteoarthritis.

• vanadiumScientific

  Vanadium accumulates in bone and stimulates osteoblast differentiation while inhibiting osteoclast activity in preclinical models. Animal deficiency studies show skeletal deformations; in vitro studies confirm vanadate stimulates bone cell proliferation. Evidence is entirely preclinical with no human RCT data for musculoskeletal outcomes.

• vitamin AScientific

  Vitamin A influences bone metabolism through retinoic acid receptors on osteoblasts and osteoclasts, affecting both bone formation and resorption. Both deficiency and excess are associated with adverse skeletal outcomes. Human epidemiological studies show associations between vitamin A intake and bone mineral density, though the relationship is complex and dose-dependent.

• vitamin B12Scientific

  Vitamin B12 status influences musculoskeletal health primarily through its effects on bone mineral density via homocysteine metabolism and potential direct effects on osteoblasts. Low B12 has been linked to reduced BMD and increased fracture risk in observational studies, with inconsistent findings from intervention trials.

• vitamin CScientific

  Vitamin C (ascorbic acid) plays a well-established biochemical role in musculoskeletal health, acting as an essential cofactor for collagen hydroxylation and osteoblast differentiation. Preclinical evidence supports its capacity to accelerate bone healing, increase type I collagen synthesis, and reduce oxidative stress in bone, tendon, and ligament tissues. Human observational data link higher vitamin C intake to greater bone mineral density, particularly in postmenopausal women. However, the number of controlled clinical trials in humans remains limited, and results are mixed, meaning the scientific evidence, while real, is not yet conclusive for therapeutic supplementation.

• vitamin DScientific

  Vitamin D is essential for musculoskeletal health, supporting calcium absorption, bone mineralization, and skeletal muscle function. Deficiency causes rickets in children, osteomalacia and proximal muscle weakness in adults, and is associated with increased fracture and fall risk. Clinical evidence supports supplementation—particularly at doses above 700–800 IU/day—especially in older and deficient populations, though evidence for benefit in already-sufficient individuals is more limited and debated.

• vitamin D3Scientific

  Vitamin D3 (cholecalciferol) has well-established, clinically documented roles in musculoskeletal health. It enhances intestinal calcium and phosphorus absorption critical for bone mineralization, and its deficiency causes rickets in children, osteomalacia and proximal muscle weakness in adults. Combined vitamin D3 and calcium supplementation has been shown in meta-analyses of RCTs to modestly reduce fracture risk, though vitamin D3 alone shows inconsistent fracture outcomes. Skeletal muscle also expresses the vitamin D receptor, and deficiency is associated with muscle atrophy and impaired strength.

• vitamin KScientific

  Vitamin K plays a well-documented role in musculoskeletal health, primarily through its function as a cofactor for γ-carboxylation of osteocalcin and matrix Gla protein, both critical to bone mineralization and integrity. Multiple systematic reviews and meta-analyses of RCTs demonstrate that vitamin K supplementation reduces fracture risk, particularly vertebral and clinical fractures, in postmenopausal and osteoporotic populations. Evidence also links vitamin K status to joint health (osteoarthritis) and skeletal muscle function (sarcopenia), though RCT findings in these latter areas remain inconclusive.

• wasabiScientific

  Wasabi supports the musculoskeletal system through two distinct pathways: anti-inflammatory COX-2/iNOS suppression relevant to joint and soft tissue inflammation, and bone-protective osteogenic effects via HCA from wasabi leafstalk. These mechanisms address both inflammatory and degenerative musculoskeletal conditions. All evidence is preclinical.

• whey proteinScientific

  Whey protein is extensively studied for musculoskeletal applications including muscle protein synthesis, resistance to sarcopenia, recovery from exercise-induced damage, and bone density in combination with resistance training. Meta-analyses confirm whey increases lower-body muscular strength in older adults. The FrOST RCT demonstrated significant improvements in BMD and sarcopenia Z-score with whey supplementation combined with high-intensity resistance training.

• white willowScientific

  White willow bark has the strongest clinical evidence base of any herbal remedy for musculoskeletal pain. Multiple RCTs and a 2014 Cochrane review support its efficacy for chronic low back pain and osteoarthritis. NCCIH recognizes its use for musculoskeletal conditions. The German Commission E approves it for rheumatic ailments.

• willowScientific

  Willow bark's strongest clinical evidence domain is musculoskeletal pain, including low back pain and osteoarthritis. Multiple RCTs and a 2009 systematic review covering four clinical trials provide moderate evidence of effectiveness. The 2023 meta-analysis of 6 RCTs (329 arthritis patients) showed significant pain relief and improved physical function vs. placebo. The EMA, ESCOP, and Health Canada monographs all formally recognize musculoskeletal applications.

• wintergreenScientific

  Wintergreen's primary constituent methyl salicylate is FDA-approved for topical musculoskeletal pain relief and is widely used in OTC liniments and patches for muscle and joint conditions. Multiple clinical trials and a large real-world study (n=3,515) support efficacy for soft tissue musculoskeletal pain. The plant is a traditional remedy for rheumatic and musculoskeletal complaints across multiple cultures.

• withanolidesScientific

  Withanolides, the bioactive steroidal lactones from Withania somnifera (ashwagandha), have human clinical trial evidence supporting their role in muscle strength, muscle recovery, and joint health. Multiple RCTs show significant improvements in muscle strength and size in resistance-trained adults, while separate trials in osteoarthritis and rheumatoid arthritis patients report reduced pain, stiffness, and disability. The primary mechanisms involve inhibition of pro-inflammatory pathways (NF-κB, JAK/STAT) and modulation of stress hormones such as cortisol, creating a favorable environment for muscle anabolism and joint protection.

• yuccaScientific

  Arthritis, joint pain, and musculoskeletal inflammation are the best-supported clinical indications for yucca, with a 1975 double-blind trial showing benefit in OA and RA patients. Native American use of yucca for arthritis, sprains, and rheumatism is extensively documented. Saponins and yuccaols provide anti-inflammatory, anti-spasmodic, and analgesic mechanisms relevant to musculoskeletal conditions.

• zeoliteScientific

  Zeolite clinoptilolite has demonstrated effects on bone in a randomized double-blind placebo-controlled human trial and an ovariectomized rat model, showing increased bone mineral density, improved bone formation markers, and reduced bone resorption. Silicon released from zeolite supports osteoblast activity and collagen synthesis. A 4-year clinical trial in osteoporosis patients further tracked musculoskeletal-relevant mineral changes.

• zincScientific

  Zinc is an essential trace element with well-documented roles in bone and muscle physiology. Approximately 80% of total body zinc resides in skeletal muscle and bone tissue, where it participates in osteoblast differentiation, collagen matrix synthesis, and the regulation of bone remodeling. Clinical and epidemiological studies consistently link higher serum zinc with greater bone mineral density (BMD), and zinc supplementation has demonstrated measurable increases in BMD in deficient populations. Evidence for muscle-specific benefits (e.g., sarcopenia prevention) is associative rather than interventional at this stage.

• abies spectabilisTraditional

  A. spectabilis is traditionally used for rheumatism and bone fractures in Himalayan folk medicine, with external paste preparations applied to fracture sites. Preclinical anti-inflammatory and analgesic activity provides mechanistic support.

• alfalfaTraditional

  Alfalfa's traditional use for arthritis and its content of calcium, vitamin K, vitamin D, magnesium, and phytoestrogens connect it to musculoskeletal health. Anti-inflammatory activity of its flavonoids is mechanistically relevant. No clinical trials have evaluated musculoskeletal endpoints directly.

• almondTraditional

  Almonds contain calcium, magnesium, phosphorus, and protein—all established contributors to muscle and bone maintenance. Preclinical data and epidemiological associations support vitamin E's role in reducing oxidative stress–driven bone loss. However, direct human RCTs specifically examining almonds and musculoskeletal outcomes are not yet available.

• atractylodesTraditional

  Atractylodes macrocephala (and especially A. lancea) has a longstanding TCM use for wind-cold-damp arthralgia, muscle weakness, and limb heaviness. The anti-inflammatory pharmacology of atractylenolides supports this traditional application, though human musculoskeletal-specific clinical trials are lacking.

• birchTraditional

  Birch has documented traditional use for musculoskeletal conditions including rheumatism, arthritis, gout, and muscle pain, endorsed by ESCOP and the German Commission E. Methyl salicylate in birch bark provides analgesic and anti-inflammatory activity. Betulin and betulinic acid have demonstrated anti-inflammatory efficacy comparable to indomethacin in animal models.

• black cohoshTraditional

  Black cohosh has a centuries-long tradition of use for musculoskeletal pain, rheumatism, and muscle soreness. Native American tribes and 19th-century eclectic physicians used it specifically for rheumatic and myalgic pain. Modern scientific evaluation of this body system use remains mostly confined to combination preparations or mechanistic data.

• bladderwrackTraditional

  Bladderwrack's anti-inflammatory fucoidan and mineral content support joint and muscle tissue, with traditional use for rheumatic and arthritic musculoskeletal conditions. Fucoidan reduces joint swelling in animal models. Human clinical musculoskeletal trials for bladderwrack are absent.

• bonesetTraditional

  The very name 'boneset' reflects traditional use for severe musculoskeletal aching associated with febrile illness ('breakbone fever'). Native American and Eclectic traditions document its use for deep bone and muscle pain during influenza and for muscular rheumatism. In vitro anti-inflammatory data from sesquiterpene lactones provides biological plausibility. No clinical trials for musculoskeletal indications exist.

• cajuputTraditional

  Cajuput oil is among the most consistently documented traditional treatments for the musculoskeletal system, used across Southeast Asia, Australia, and Ayurveda for muscle pain, joint pain, arthritis, rheumatism, and neuralgia. It is a component of Tiger Balm and Minyak Telon. A 2025 bibliometric review identified MCEO muscle health as an active research area.

• dioscoreaTraditional

  Wild yam is traditionally used for musculoskeletal complaints including joint pain, rheumatism, and muscle spasms. Preclinical evidence shows antinociceptive effects and muscle-fiber benefits from diosgenin. Human evidence is absent.

• feverfewTraditional

  Feverfew has traditional use for muscle tension, pain, and spasm across European and classical herbal traditions. Its antispasmodic properties and prostaglandin-inhibiting effects provide a pharmacological rationale. No clinical trials specifically targeting musculoskeletal outcomes have been published.

• gooseberryTraditional

  Traditional Ayurvedic medicine uses amla for arthritis and joint conditions under the category of 'vata' disorders. WebMD/NLM documents its use for osteoarthritis. Anti-inflammatory clinical evidence (CRP reduction) is indirectly supportive, but no musculoskeletal-specific RCTs exist.

• greek mountain teaTraditional

  GMT has documented traditional use for rheumatic and musculoskeletal disorders, with preclinical anti-inflammatory evidence supporting pain and swelling reduction. Bone protection in animal osteoporosis models provides additional musculoskeletal relevance. Traditional use as analgesic and anti-rheumatic is consistent across Balkan ethnobotany.

• gymnema sylvestreTraditional

  Gymnema sylvestre is documented in Ayurveda for arthritis, osteoporosis, and rheumatism—all musculoskeletal conditions. Preclinical animal evidence shows anti-inflammatory paw-swelling reduction relevant to arthritis. No dedicated human musculoskeletal trials have been published.

• haliotisTraditional

  TCM traditionally uses Shi Jue Ming for osteoporosis and arthritis. An in vitro study found Haliotis discus hannai gastrointestinal digests promote osteoblast differentiation, providing preliminary preclinical support for musculoskeletal applications.

• horse chestnutTraditional

  Horse chestnut has a documented traditional use for musculoskeletal complaints including rheumatism, joint pain, sprains, and back pain. Topical aescin preparations have preliminary clinical support for post-traumatic soft tissue swelling. Traditional herbalism and folk medicine across Europe consistently employed horse chestnut for these indications.

• horseradishTraditional

  Horseradish has Commission E-approved topical use for minor muscle aches and joint pain via rubefacient counter-irritation. European herbalists used it for rheumatism, arthritis, sciatica, and gout. The pungent AITC produces local vasodilation and counter-irritant analgesia. No human clinical trials exist for musculoskeletal outcomes.

• kavaTraditional

  Kava is documented in traditional Pacific medicine and Western herbalism as a muscle relaxant and analgesic for musculoskeletal conditions including rheumatism, muscle tension, and joint pain. Kavalactones exhibit spasmolytic activity on smooth and skeletal muscle in preclinical models and inhibit COX enzymes. No human musculoskeletal RCT exists.

• muira puamaTraditional

  Muira puama is traditionally used both orally and topically for musculoskeletal complaints including rheumatism, joint pain, and muscle paralysis. Its use for these conditions is documented across Amazonian folk medicine, Brazil, Germany, and the British Herbal Pharmacopoeia. Anti-inflammatory phytochemicals (diterpenoids) provide limited biological plausibility.

• punarnavaTraditional

  Punarnava is classified in Ayurveda as 'Shotha Nashana' (anti-swelling/anti-inflammatory) and is used in classical formulations (Narayan Oil, Punarnavadi Guggulu) for arthritis, gout, neuralgia, and musculoskeletal pain. External leaf poultices for joint aches are documented across tribal medicine. Preclinical anti-arthritic and anti-inflammatory evidence provides mechanistic support.

• solomon's sealTraditional

  The musculoskeletal system is the primary organ system associated with Solomon's seal in Western herbal medicine. Documented traditional applications span joint pain, arthritis, sprains, tendon injuries, back pain, and bone repair across European, TCM, North American indigenous, and Ayurvedic traditions.

• szechuan lovageTraditional

  CX is traditionally used in TCM for musculoskeletal pain including rheumatic arthralgia, traumatic injury pain, and limb pain aggravated by cold or damp. Its analgesic and blood-activating properties address pain attributed to blood stasis or qi stagnation in muscles and joints. Formal clinical trials for musculoskeletal outcomes specifically are not established.

• watercressTraditional

  Watercress is documented in traditional medicine as a remedy for arthritis, rheumatic pain, and weak bones across Iranian, European, Moroccan, and other folk medicine systems. Its vitamin K1 and calcium content provide a nutritional basis for bone support. No dedicated musculoskeletal clinical trial for watercress has been conducted.

• wild yamTraditional

  Wild yam is classified as an antirheumatic and muscle relaxant throughout Western herbal medicine, used for joint pain, arthritis, muscle cramps, and neuralgia. The folk name 'rheumatism root' captures this tradition. Preclinical studies provide anti-inflammatory and antinociceptive support; human trials are absent.

• xanthium (cockleburs)Traditional

  The musculoskeletal system—encompassing joints, muscles, and connective tissue—is a primary traditional target for X. strumarium in TCM, used for rheumatism, arthralgia, lumbago, and joint pain. Preclinical anti-inflammatory and analgesic studies support the traditional rationale. This is one of the oldest documented uses of the plant.